(2S,4R)-1-BOC-4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID ETHYL ESTER, 97%, 25g

4-Amino- N -(4-chloro-phenyl)-benzenesulfonamide, 95.0%, 100mg

Prohibition signs in accordance with ISO 7010 Adhesive foil, Fire, open light and smoking prohibited, 400 mm, 1 piece

Thalidomide-O-amido-C8-NH2 (TFA), 100mg

2-Hydroxy-5-methylpyrazine, 98.0%, 5g

1-(tert-Butyl) 2-methyl (2R,3R)-3-hydroxypyrrolidine-1,2-dicarboxylate, 95%, 500mg

3-(4-Chloro-2-methylphenoxy)azetidine, 95+%, 5g

ethyl 2-amino-3-(1,3-benzothiazol-2-yl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-carboxylate, 95.0%, 500mg

3-phenylpyridin-2-ylamine, 95.0%, 250mg

4'-Hydroxyacetophenone>98.0%(HPLC)(T)100g

2-Cyclopentyl-2-phenylethan-1-amine, 95+%, 10g

4-Nitro-1H-pyrrolo[2,3-b]pyridine 7-oxide, 95.0%, 250mg

N-(1H-1,2,3-Benzotriazol-1-ylmethyl)benzenecarbothioamide, 1g